Sakar Healthcare Stock Surges on EU Approval

  Published 1 year ago

Sakar Healthcare shares rise 5% after EU approval for cancer drug, with more product approvals expected soon.

  • India’s Sakar Healthcare gains 5% as EU approves colorectal cancer injection.
  • The company expects EU approvals for oral solids and injections in the next months.
  • Trading volume triples to 115k shares; stock up 16% year to date.

You might like these

India’s Fiscal Deficit Doubles in Q1

Godavari Biorefineries Hits 5% High

Varun Beverages Q2: Resilient Despite Rains

HDFC Bank to Adjust ADS Post Bonus Issue

India's Economic Resilience Amid Global Headwinds

LTTS Q1 Profit Flat, Revenue Up 16%

Indian Hotels Sells Leanluxe Hospitality to Tata Sons

News that matters the most ⚡